1-5 of 5
Patricia Cozar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5801: Identifying vulnerabilities to immune checkpoint inhibitors of oncogene-addicted non-small cell lung cancer subgroups

Free
Inés Díaz-Cano, José Gracia, Patricia Cozar, Belén Revuelta, Nuria Carrizo, Juan Dubrot, Luis Paz-Ares, Itziar Otano
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 5801.
https://doi.org/10.1158/1538-7445.AM2025-5801
Published: 21 April 2025
View articletitled, Abstract 5801: Identifying vulnerabilities to immune checkpoint inhibitors of oncogene-addicted non-small cell lung cancer subgroups
Journal Articles

Abstract 5837: Lurbinectedin-induced transcriptional reprogramming: A pathway to sensitise SCLC to immunotherapy

Free
Joan Salvador Russo-Cabrera, Santiago Ponce-Aix, Patricia Cozar, Alicia Luengo, Belén Revuelta, Laura García-Redondo, Alejandro Navarro, Reyes Bernabé, María Eugenia Olmedo, José Manuel Trigo, Jon Zugazagoitia, Luis Paz-Ares, Itziar Otano
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 5837.
https://doi.org/10.1158/1538-7445.AM2025-5837
Published: 21 April 2025
View articletitled, Abstract 5837: Lurbinectedin-induced transcriptional reprogramming: A pathway to sensitise SCLC to immunotherapy
Journal Articles

Abstract 924: Predictive biomarker identification for combined anti-mTOR and anti-IGF-1R treatment in luminal B breast cancer

Free
Martin A. Rivas, Yasir H. Ibrahim, Olga Rodríguez, Pilar Antón, Patricia Cozar, Patricia Gómez-Pardo, Claudia Aura, Brian B. Haines, Sriram Sathyanarayanan, Theresa Zhang, Violeta Serra, José Baselga
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 924.
https://doi.org/10.1158/1538-7445.AM2014-924
Published: 01 October 2014
View articletitled, Abstract 924: Predictive biomarker identification for combined anti-mTOR and anti-IGF-1R treatment in luminal B breast cancer
Journal Articles

Abstract 3746: PI3K inhibition sensitizes to PARP inhibitors in patient-derived xenograft models of triple negative breast cancer

Free
Yasir H. Ibrahim, Celina García-García, Violeta Serra, Maurizio Scaltriti, Dejan Juric, Pilar Anton, Marta Guzman, Patricia Cozar, Claudia Aura, Jose Jimenez, Isabel Rubio, Jose Perez, Judith Balmana, Jose Baselga
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3746.
https://doi.org/10.1158/1538-7445.AM2012-3746
Published: 15 April 2012
View articletitled, Abstract 3746: PI3K inhibition sensitizes to PARP inhibitors in patient-derived xenograft models of triple negative breast cancer
Journal Articles

A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion

Available to Purchase
Javier Santos, Laura González-Sánchez, María Matabuena-deYzaguirre, María Villa-Morales, Patricia Cozar, Pilar López-Nieva, Pablo Fernández-Navarro, Manuel Fresno, Manuel D. Díaz-Muñoz, Jean-Louis Guenet, Xavier Montagutelli, José Fernández-Piqueras
Journal: Cancer Research
Cancer Res (2009) 69 (6): 2577–2587.
https://doi.org/10.1158/0008-5472.CAN-08-1821
Published: 17 March 2009
View articletitled, A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
Open the PDF for A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion in another window
Includes: Supplementary data